1. Louis DN, Ohgaki H, Wiestler OD, Cavenne C, editors. WHO classification of tumours of the central nervous system. 4th ed. Lyon: IARC; 2016.
2. Del Basso De Caro M, Solari D, Pagliuca F, et al. Atypical pituitary adenomas: clinical characteristics and role of ki-67 and p53 in prognostic and therapeutic evaluation. A series of 50 patients. Neurosurg Rev. 2017;40(1):105–14.
3. Carroll PV, Jenkins PJ. Acromegaly. In: De Groot LJ, Chrousos G, Dungan K, Feingold KR, Grossman A, Hershman JM, et al., eds. Endotext. 2016. https://www.ncbi.nlm.nih.gov/books/NBK279097/ . Accessed 11 June 2018.
4. Asa SL, Kucharczyk W, Ezzat S. Pituitary acromegaly: not one disease. Endocr Relat Cancer. 2017;24(3):C1–4.
5. Newell-Price J, Bertagna X, Grossman AB, Nieman LK. Cushing’s syndrome. Lancet. 2006;367(9522):1605–17.